Joining forces in the battle against cancer, myocardial infarction or Alzheimer’s disease
Together with the German Federal Ministry of Research and Education, five German pharmaceutical and medical device companies are starting the “Technology Initiative Molecular Imaging“
Bayer Schering Pharma, Boehringer Ingelheim Pharma, Siemens Medical Solutions, Karl Storz and Carl Zeiss will spend a total of 750 million Euros during the next ten years for the development of new methods in molecular imaging. In the next six years, BMBF will also promote cooperative R&D projects in the amount of 150 million Euros.
|Joint Press Release by Bayer Schering Pharma, Boehringer Ingelheim Pharma, Siemens Medical Solutions, Karl Storz und Carl Zeiss||